Verax Corp

Company Information

Company Name
Verax Corp
Address
Etna Rd Hc 61 Box 6
Lebanon, NH, 03766
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$455,427.00
10
SBIR Phase II
$640,930.00
2
Chart code to be here

Award List

  1. CONTINUOUS CELL CULTURE FOR MONOCLONAL ANTIBODIES

    Amount: $434,930.00

    THE OBJECTIVE FOR THIS PROJECT IS TO PROVE THE FEASIBILITY OF THE RESEARCH PLAN FOR A PHASE II PROGRAM TO DEMONSTRATE A LARGE COST REDUCTION FOR THE "IN VITRO" PRODUCTION OF MONOCLONAL ANTIBODIES. ACC ...

    SBIR Phase II 1984 Department of Health and Human Services
  2. MATHEMATICAL MODELING OF MAMMALIAN CELLS

    Amount: $206,000.00

    THE RECENT DEVELOPMENT OF MOLECULAR BIOLOGY, PARTICULARLY INTHE FIELD OF RECOMBINANT DNA TECHNOLOGY, GIVES BIRTH TO A NEW ERA IN MEDICAL THERAPEUTICS AND DIAGNOSTICS USING PRODUCTS FROM MAMMALIAN CELL ...

    SBIR Phase II 1987 National Science Foundation
  3. THE OBJECTIVE OF THIS PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF EFFICIENTLY PRODUCING BIOCHEMICALS FROM MAMMALIAN FIBROBLASTS BY A NOVEL METHOD OF CONTINUOUS CULTURE WITH IMMOBILIZED CELLS.

    Amount: $38,378.00

    THE OBJECTIVE OF THIS PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF EFFICIENTLY PRODUCING BIOCHEMICALS FROM MAMMALIAN FIBROBLASTS BY A NOVEL METHOD OF CONTINUOUS CULTURE WITH IMMOBILIZED CELLS. THE NOV ...

    SBIR Phase I 1985 Department of Health and Human Services
  4. THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF A NOVEL APPROACH TO CULTURING CELLS IN ORDER TO PRECISELY DETERMINE THEIR RESPONSE TO ENVIRONMENTAL CHANGES.

    Amount: $46,976.00

    THE OBJECTIVE OF THIS PHASE I PROJECT IS TO DEMONSTRATE THE FEASIBILITY OF A NOVEL APPROACH TO CULTURING CELLS IN ORDER TO PRECISELY DETERMINE THEIR RESPONSE TO ENVIRONMENTAL CHANGES. THIS APPROACH WI ...

    SBIR Phase I 1985 Department of Health and Human Services
  5. THE CULTURE ENVIRONMENT IN WHICH A MAMMALIAN CELL IS MAINTAINED CAN PROFOUNDLY INFLUENCE ITS STATE OF DIFFERENTIATION AND ITS LONGEVITY AS WELL AS ITS GROWTH RATEAND PRODUCTIVITY.

    Amount: $50,000.00

    THE CULTURE ENVIRONMENT IN WHICH A MAMMALIAN CELL IS MAINTAINED CAN PROFOUNDLY INFLUENCE ITS STATE OF DIFFERENTIATION AND ITS LONGEVITY AS WELL AS ITS GROWTH RATEAND PRODUCTIVITY. VERAX CORPORATION HA ...

    SBIR Phase I 1986 Department of Health and Human Services
  6. WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, TWO THINGS HAVE BECOME INCREASINGLY OBVIOUS: 1.

    Amount: $47,000.00

    WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, TWO THINGS HAVE BECOME INCREASINGLY OBVIOUS: 1. THESE MOLECULESWILL BE NEEDED IN KILOGRAM QUANTITIES FOR THE TREATMENT OF AVARIETY OF MALIGNANCIES. 2 ...

    SBIR Phase I 1986 Department of Health and Human Services
  7. THE USE OF IN VITRO PRODUCED MONOCLONAL ANTIBODIES FOR THE TREATMENT OF IMMUNOLOGIC, INFECTIOUS, AND NEOPLASTIC DISEASES IN HUMANS IS PROJECTED TO INCREASE SHARPLY IN THE UPCOMING YEARS.

    Amount: $50,000.00

    THE USE OF IN VITRO PRODUCED MONOCLONAL ANTIBODIES FOR THE TREATMENT OF IMMUNOLOGIC, INFECTIOUS, AND NEOPLASTIC DISEASES IN HUMANS IS PROJECTED TO INCREASE SHARPLY IN THE UPCOMING YEARS. VERAX CORPORA ...

    SBIR Phase I 1986 Department of Health and Human Services
  8. A NOVEL SYSTEM FOR HUMAN HYBRIDOMA CULTURE

    Amount: $43,000.00

    WITH THE ADVENT OF MONOCLONAL ANTIBODY TECHNOLOGY, IT HAS BECOME CLEAR THAT THERE IS A GROWING NEED TO PRODUCE HUMAN CELLS AND CELL PRODUCTS IN LARGER QUANTITIES FOR THE TREATMENT OF VARIOUS IMMUNOLOG ...

    SBIR Phase I 1987 Department of Health and Human Services
  9. DEFINED MEDIA FOR CONTINUOUS CULTURE OF MAMMALIAN CELLS

    Amount: $48,000.00

    WITH THE ADVENT OF GENETIC ENGINEERING TECHNOLOGY, IT HAS BECOME CLEAR THAT THERE IS A GROWING NEED TO PRODUCE CLONED CELL PRODUCTS IN LARGER QUANTITIES FOR THE TREATMENT OF VARIOUS CARDIOVASCULAR, IM ...

    SBIR Phase I 1988 Department of Health and Human Services
  10. PRODUCTION OF HIV GP-120 PROTEIN

    Amount: $50,000.00

    THE TERMINAL NATURE OF HIV INFECTIONS HAS PROMPTED DEMANDS FOR LARGE QUANTITIES OF HIV PROTEINS FOR RESEARCH RELATED TO UNDERSTANDING THE VIRUS AND DEVELOPING THERAPEUTIC TREATMENTS. VERAX CORPORATION ...

    SBIR Phase I 1989 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government